Medicare Enrolled

Dr. Kailash Kedia, M.D.

Optician · Garfield Heights, OH
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
1 INFINITY CORPORATE CENTRE DR STE 101, Garfield Heights, OH 44125
4408916500
Registered in NPPES since 2006
NPI: 1548240286 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kedia from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kedia? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Kedia

Dr. Kailash Kedia is an optician specialist in Garfield Heights, OH, with 20 years of NPI registration. Based on federal Medicare data, Dr. Kedia performed 9,790 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Kedia received a total of $31,102 from 73 pharmaceutical and/or device companies across 493 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Kedia is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration ▲ Top 3% volume in OH $31,102 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
9,790
Medicare services
Top 3% in OH for optician
Not available
Unique patients (not deduplicated)
$39
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Leuprolide injectable, camcevi, 1 mg 1,890 $68 $190
Manual urinalysis with microscopic examination
A urine test performed manually without automated equipment. The sample is examined under a microscope to check for abnormalities.
1,183 $4 $10
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
915 $7 $9
Denosumab injection (Prolia/Xgeva) 780 $18 $32
PSA test (prostate cancer screening) 664 $18 $50
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
664 $85 $200
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
499 $9 $45
Testosterone injection
An injection of testosterone cypionate, a form of testosterone hormone. The dose is measured in milligrams.
388 $0 $0
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
381 $59 $135
Hospital follow-up visit, low complexity
Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service.
287 $38 $75
Free PSA test
A blood test that measures the amount of unbound prostate-specific antigen in the blood.
273 $18 $50
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
255 $33 $80
Total testosterone level test
A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women.
239 $25 $55
Leuprolide acetate (for depot suspension), 7.5 mg 153 $135 $410
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
152 $61 $140
Urine culture, bacterial colony count
A laboratory test that measures the number of bacteria growing in a urine sample to help identify infections.
131 $8 $20
Cystourethroscopy
A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract.
115 $160 $420
Subcutaneous or intramuscular chemotherapy injection
This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle.
99 $22 $70
PSA test (prostate cancer screening)
A blood test that measures the level of prostate-specific antigen to screen for prostate cancer.
99 $19 $50
Injection, garamycin, gentamicin, up to 80 mg 99 $2 $60
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
61 $99 $315
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
58 $134 $390
Transrectal ultrasound of the pelvis
An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures.
57 $90 $275
Electronic assessment of bladder emptying
A test that uses electronic monitoring to evaluate how well the bladder empties urine.
45 $5 $85
Prostate gland biopsy
A procedure to remove small samples of tissue from the prostate gland for laboratory examination.
42 $98 $460
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
38 $98 $260
Imaging of urinary tract with contrast
An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures.
33 $19 $70
Non-needle muscle activity measurement of bladder and bowel openings
This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles.
24 $24 $400
Abdominal device insertion with pressure and urine flow study
A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate.
24 $142 $265
Ureteral stent insertion via endoscope
A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder.
21 $74 $1,006
Complex urodynamic pressure measurement
A test that measures the pressure of urine flow in the bladder along with urethral and voiding pressures.
20 $282 $655
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
18 $92 $200
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
17 $47 $60
Cystoscopy with chemical ablation of bladder
A procedure where a camera is used to examine the bladder and a chemical agent is applied to destroy abnormal tissue.
14 $129 $600
New patient office visit, 15-29 minutes
An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold.
14 $51 $140
Shock wave crushing of kidney stones
A procedure that uses shock waves to break kidney stones into smaller pieces so they can pass more easily from the body.
13 $436 $1,590
Bladder and urethra clot removal with endoscope
A procedure using an endoscope to irrigate and remove multiple blood clots from the bladder and urethra.
13 $218 $735
Ureteral stent insertion via cystoscopy
A tube is placed into the ureter using an endoscope inserted through the bladder.
12 $100 $540
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
0.5% high complexity
20.4% medium
79.1% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$31,102
Total received (2018-2024)
Avg $4,443/year across 7 years
Top 8% in OH for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
73
Companies
493
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$4,119
2023
$3,973
2022
$2,763
2021
$2,141
2020
$3,030
2019
$9,006
2018
$6,071

Payments by company (2024)

Dendreon Pharmaceuticals LLC
$842
COLOPLAST CORP
$788
Olympus America Inc.
$465
Sumitomo Pharma America, Inc.
$384
Myriad Genetic Laboratories, Inc.
$198
Blue Earth Diagnostics Limited
$194
Axonics, Inc.
$176
Amgen Inc.
$150
Verity Pharmaceuticals Inc.
$139
Tolmar, Inc.
$135
Novo Nordisk Inc
$125
Agiliti Surgical, Inc.
$104
Astellas Pharma US Inc
$98
PFIZER INC.
$71
DENTSPLY IH AB
$54
AstraZeneca Pharmaceuticals LP
$38
Bayer Healthcare Pharmaceuticals Inc.
$37
PROCEPT BioRobotics Corporation
$28
PROGENICS PHARMACEUTICALS, INC.
$20
Merck Sharp & Dohme LLC
$20
ABBVIE INC.
$19
ACCORD HEALTHCARE, INC.
$18
Integra LifeSciences Corporation
$17
Top 3 companies account for 50.9% of 2024 payments
All-time payments by company (2018-2024) ›
Integra GPO, LLC
$9,926
Dendreon Pharmaceuticals LLC
$3,514
Coloplast Corp
$2,932
Astellas Pharma US Inc
$1,454
COLOPLAST CORP
$1,073
UC-CARE (USA), INC
$911
Medline Industries, Inc.
$885
Olympus America Inc.
$798
Myovant Sciences Inc.
$755
AstraZeneca Pharmaceuticals LP
$632
Sumitomo Pharma America, Inc.
$621
Blue Earth Diagnostics Limited
$512
TOLMAR Pharmaceuticals, Inc.
$451
Axonics Modulation Technologies, Inc.
$419
Myriad Genetic Laboratories, Inc.
$382
FEMSelect Inc.
$341
PFIZER INC.
$288
Boston Scientific Corporation
$242
Medtronic, Inc.
$240
Axonics, Inc.
$238
UroGen Pharma, Inc.
$233
Amgen Inc.
$205
Bayer Healthcare Pharmaceuticals Inc.
$193
Janssen Biotech, Inc.
$162
PROCEPT BioRobotics Corporation
$158
Novo Nordisk Inc
$150
Augmenix, Inc.
$146
Becton, Dickinson and Company
$143
Integra LifeSciences Corporation
$139
Verity Pharmaceuticals Inc.
$139
Accord Healthcare, Inc.
$137
Endo Pharmaceuticals Inc.
$137
Tolmar, Inc.
$135
ACELL, INC.
$125
GlaxoSmithKline, LLC.
$125
Palette Life Sciences, Inc.
$124
E.R. Squibb & Sons, L.L.C.
$120
Merck Sharp & Dohme LLC
$106
Agiliti Surgical, Inc.
$104
AbbVie Inc.
$100
Bayer HealthCare Pharmaceuticals Inc.
$100
AbbVie, Inc.
$97
HealthTronics Mobile Solutions, LLC
$96
PALETTE LIFE SCIENCES, INC.
$91
NxThera, Inc.
$85
Ferring Pharmaceuticals Inc.
$85
Kowa Pharmaceuticals America, Inc.
$82
Zyla Life Sciences, Inc.
$81
DENTSPLY IH AB
$80
Progenics Pharmaceuticals, Inc.
$75
Acerus Pharmaceuticals Corporation
$73
MEDIVATION FIELD SOLUTIONS LLC
$66
Caldera Medical, Inc
$59
Ethicon US, LLC
$48
Mission Pharmacal Company
$44
UROVANT SCIENCES INC
$43
UROGEN PHARMA, INC.
$38
Sun Pharmaceutical Industries Inc.
$38
Antares Pharma, Inc.
$35
C. R. Bard, Inc. & Subsidiaries
$31
Zyla Life Sciences
$28
Assertio Therapeutics, Inc.
$24
Stryker Corporation
$23
GENZYME CORPORATION
$23
ConvaTec Inc.
$23
Merck Sharp & Dohme Corporation
$22
PROGENICS PHARMACEUTICALS, INC.
$20
ABBVIE INC.
$19
ACCORD HEALTHCARE, INC.
$18
Foundation Medicine, Inc.
$17
BOSTON SCIENTIFIC CORPORATION
$15
Renovia Inc
$15
DENTSPLY IH Inc.
$12
Top 3 companies account for 52.6% of all-time payments
Associated products mentioned in payments ›
100% Silicone Foley Catheter Total 1_Lay · 1688 · ALTIS · AMS 700 CXR RTE KIT · AQUABEAM ROBOTIC SYSTEM · AQUABEAM SYSTEM · AXIS · Altis · Aquoral · Axonics · Axonics r-SNM System · Axumin · BREZTRI · Bulkamid · CAMCEVI · Coloplast TFL Drive · Desara · ELIGARD · ELIQUIS · ENPLACE · ERASE CAUTI Total Trays · ERLEADA · Echelon Flex · Endoscopy Light Bulbs by Stryker · FEMALE INCONTINENCE · FIRMAGON · GELFOAM · GEMTESA · GENERAL BPH · GENERAL - BPH · GENTLECATH · GI Genius · Genesis · INTEGRA MESHED BILAYER WOUND MATRIX · INTERSTIM · Isiris · JELMYTO · JEVTANA · KEYTRUDA · Kerendia · LOFRIC · LOKELMA · LUPRON DEPOT · LYNPARZA · LoFric · Lupron · Lupron Depot · MYRBETRIQ · MYRISK · Mobile Cryoblation Services · Mobile Laser Services · Myrbetriq · NAVIGO WORKSTATION · NOCDURNA · Natesto · Nubeqa · OMNIGRAFT · ORGOVYX · PELVIC FLOOR REPAIR · PENILE & TESTICULAR RECONSTRUCTN · POSLUMA · PRECISETUMOR · PROGEL · PROLARIS · PROVENGE · PYLARIFY · Porges Coloplast · Prolaris · Prolia · RESTORELLE · Repatha · Rezum · SEGLENTIS · SPEEDICATH · SPRIX · SURGICEL Family of Absorbable Hemostats · SUSPEND · Saffron · Sonablate HIFU · SpaceOAR · SpeediCath · THROMBIN-JMI · TITAN · TOVIAZ · Titan · Trelstar · Tresiba · Virtue · XIAFLEX · XTANDI · Xofigo · Xtandi · YONSA · ZIPSOR · ZYTIGA · iTIND System · leva Pelvic Floor Trainer
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for an optician specialist in Garfield Heights?
Compare opticians in the Garfield Heights area by procedure volume, costs, and industry payment transparency.
Browse opticians nearby

Geographic Context

Opticians in nearby ZIP areas
318
County median income
$62,823
Nearest hospital to ZIP centroid (approximate)
MARYMOUNT HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Kedia is a mixed practice specialist, with above-average Medicare volume (top 3% in OH), with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Kedia experienced with leuprolide injectable, camcevi, 1 mg?
Based on Medicare claims data, Dr. Kedia performed 1,890 leuprolide injectable, camcevi, 1 mg services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Kedia receive payments from pharmaceutical companies?
Yes. Dr. Kedia received a total of $31,102 from 73 companies across 493 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kedia's costs compare to other opticians in Garfield Heights?
Dr. Kedia's average Medicare payment per service is $39. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kedia) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →